Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC Transplantation for Liver Cirrhosis in Biliary Atresia
NCT04522869Phase 2Completed
- Sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology
- Start
- Aug 2019
- Primary completion
- Sep 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in Liver cirrhosis (LC), biliary atresia, sponsored by Vinmec Research Institute of Stem Cell and Gene Technology. Started Aug 2019; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
Liver cirrhosis (LC)biliary atresia
Beyond the preview
Go deeper on NCT04522869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04522869.